The impact of platinum-induced peripheral neuropathy (PN) in first-line treatment on PN and efficacy in second-line paclitaxel (PTX)-based chemotherapy for unresectable advanced gastric cancer (AGC): A prospective observational multicenter study - IVY study

被引：0
|
作者：
Kono, Y. [1 ]
Tanioka, H. [2 ]
Kito, Y. [3 ]
Ando, T. [4 ]
Negoro, Y. [5 ]
Abe, T. [6 ]
Kuramochi, H. [7 ]
Boku, S. [8 ]
Mannami, T. [9 ]
Nasu, J. [10 ]
Inoue, M. [11 ]
Nakamura, M. [12 ]
Okita, Y. [13 ]
Shindo, Y. [14 ]
Maeda, T. [15 ]
Shinohara, Y. [16 ]
Yano, S. [17 ]
Okawaki, M. [17 ]
Nagasaka, T. [17 ]
机构：
[1] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan
[2] Kawasaki Med Sch Hosp, Med Oncol Dept, Kurashiki, Okayama, Japan
[3] Ishikawa Prefectural Cent Hosp, Dept Med Oncol, Kanazawa, Ishikawa, Japan
[4] Toyama Univ Hosp, Dept Internal Med 3, Toyama, Japan
[5] Kochi Hlth Sci Ctr, Div Gastroenterol Med, Kochi, Japan
[6] Steel Mem Muroran Hosp, Dept Gastroenterol, Muroran, Hokkaido, Japan
[7] Tokyo Womens Med Univ, Dept Chemotherapy, Tokyo, Japan
[8] Kansai Med Univ, Canc Treatment Ctr, Hirakata, Osaka, Japan
[9] Natl Hosp Org Okayama Med Ctr, Dept Gastroenterol, Okayama, Japan
[10] Okayama Saiseikai Gen Hosp, Dept Internal Med, Okayama, Japan
[11] Okayama Red Cross Hosp, Dept Gastroenterol, Okayama, Japan
[12] Aizawa Hosp, Aizawa Comprehens Canc Ctr, Matsumoto, Nagano, Japan
[13] Kagawa Univ Hosp, Dept Clin Oncol, Miki, Kagawa, Japan
[14] Nakadori Gen Hosp, Dept Gastroenterol Surg, Akita, Japan
[15] Konko Hosp, Dept Surg, Asakuchi, Japan
[16] Japan Community Healthcare Org Kyushu Hosp, Dept Hematol Oncol, Kitakyushu, Fukuoka, Japan
[17] Kawasaki Med Sch Hosp, Dept Clin Oncol, Kurashiki, Okayama, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1497
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1585P
引用
收藏
页码：S883 / S883
页数：1
相关论文
共 50 条
  • [41] Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study
    Yamamoto, Yutaka
    Yamashiro, Hiroyasu
    Toh, Uhi
    Kondo, Naoto
    Nakamura, Rikiya
    Kashiwaba, Masahiro
    Takahashi, Masato
    Tsugawa, Koichiro
    Ishikawa, Takashi
    Nakayama, Takahiro
    Ohtani, Shoichiro
    Takano, Toshimi
    Fujisawa, Tomomi
    Toyama, Tatsuya
    Kawaguchi, Hidetoshi
    Mashino, Kojiro
    Tanino, Yuichi
    Morita, Satoshi
    Toi, Masakazu
    Ohno, Shinji
    BREAST CANCER, 2021, 28 (01) : 145 - 160
  • [42] Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study
    Yutaka Yamamoto
    Hiroyasu Yamashiro
    Uhi Toh
    Naoto Kondo
    Rikiya Nakamura
    Masahiro Kashiwaba
    Masato Takahashi
    Koichiro Tsugawa
    Takashi Ishikawa
    Takahiro Nakayama
    Shoichiro Ohtani
    Toshimi Takano
    Tomomi Fujisawa
    Tatsuya Toyama
    Hidetoshi Kawaguchi
    Kojiro Mashino
    Yuichi Tanino
    Satoshi Morita
    Masakazu Toi
    Shinji Ohno
    Breast Cancer, 2021, 28 (1) : 145 - 160
  • [43] Bevacizumab combined with platinum-taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial)
    Komiyama, Shinichi
    Kato, Kazuyoshi
    Inokuchi, Yuki
    Takano, Hirokuni
    Matsumoto, Takashi
    Hongo, Atsushi
    Asai-Sato, Mikiko
    Arakawa, Atsushi
    Kamiura, Shoji
    Tabata, Tsutomu
    Takeshima, Nobuhiro
    Sugiyama, Toru
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (01) : 103 - 114
  • [44] Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score: A Multicenter Study
    Nakazawa, Nobuhiro
    Sohda, Makoto
    Hosoi, Nobuhiro
    Watanabe, Takayoshi
    Kumakura, Yuji
    Yamashita, Toshiki
    Tanaka, Naritaka
    Saito, Kana
    Kimura, Akiharu
    Kasuga, Kengo
    Nakazato, Kenji
    Yoshinari, Daisuke
    Shimizu, Hisashi
    Ubukata, Yasunari
    Hosaka, Hisashi
    Sano, Akihiko
    Sakai, Makoto
    Ogawa, Hiroomi
    Shirabe, Ken
    Saeki, Hiroshi
    ANNALS OF SURGICAL ONCOLOGY, 2024, : 9023 - 9029
  • [45] Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study
    Ramalingam, Suresh S.
    Novello, Silvia
    Guclu, Salih Zeki
    Bentsion, Dmitry
    Zvirbule, Zanete
    Szilasi, Maria
    Bernabe, Reyes
    Syrigos, Konstantinos
    Byers, Lauren Averett
    Clingan, Philip
    Bar, Jair
    Vokes, Everett E.
    Govindan, Ramaswamy
    Dunbar, Martin
    Ansell, Peter
    He, Lei
    Huang, Xin
    Sehgal, Vasudha
    Glasgow, Jaimee
    Bach, Bruce A.
    Mazieres, Julien
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (32) : 3633 - +
  • [46] Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort study
    Xue Zhang
    Xin Dai
    Aina Liu
    Meili Sun
    Lei Cong
    Jing Liang
    Zimin Liu
    Zhen Li
    Jinling Zhang
    Jing Lv
    Fangli Cao
    Linli Qu
    Haiyan Liu
    Lu Yue
    Yi Zhai
    Fujun Yang
    Jiahui Chu
    Shuang Wang
    Qian Xu
    Jianyuan Zhou
    Shulun Nie
    Miao Huang
    Ruitao Xu
    Qiushi Wang
    Xinyu Song
    Di Zhang
    Zhaodi Nan
    Song Li
    Lian Liu
    BMC Medicine, 22 (1)
  • [47] Phase II Study of the Reuse of Trastuzumab with Docetaxel beyond Progression after First-Line Treatment in Second-Line Treatment for Unresectable, Metastatic Gastric Cancer (T-CORE1203)
    Takahashi, Masanobu
    Sakamoto, Yasuhiro
    Otsuka, Kazunori
    Kanbe, Mariko
    Ohori, Hisatsugu
    Shindo, Yoshiaki
    Honda, Hiroshi
    Saijo, Ken
    Ouchi, Kota
    Murakawa, Yasuko
    Takahashi, Hidekazu
    Kawai, Sadayuki
    Tanaka, Yuichi
    Yamaguchi, Takuhiro
    Shimodaira, Hideki
    Yoshioka, Takashi
    Ishioka, Chikashi
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 254 (01): : 49 - 55
  • [48] A single-arm, open-label, prospective, multicenter study of apatinib combined with chemotherapy as second-line therapy in patients with advanced gastric cancer
    Feng, J.
    Shen, B.
    Xu, J.
    Wang, Q.
    Ling, G.
    Mao, Y.
    Cai, M.
    Yang, Y.
    Mei, J.
    Han, Z.
    Wu, Y.
    Shi, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S913 - S913
  • [49] Immune checkpoint inhibitors combined with paclitaxel-based chemotherapy versus chemotherapy alone as first-line treatment in HER2-negative advanced gastric cancer: result of a multicenter retrospective study
    Fang, Yulu
    Zhao, Yifan
    Yu, Xiaofu
    Liu, Shuxun
    Tao, Gang
    Zhong, Haijun
    Xiang, Hai
    Yang, Yunshan
    Shi, Zhong
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (02) : 585 - 596
  • [50] Prospective observational cohort study of bevacizumab combined with paclitaxel as the first-or second-line chemotherapy for locally advanced or metastatic breast cancer (Study JBCRG-C05: B-SHARE)
    Kashiwaba, M.
    Yamamoto, Y.
    Yamashiro, H.
    Kondo, N.
    Nakamura, R.
    Takahashi, M.
    Toh, U.
    Tsugawa, K.
    Narui, K.
    Tamaki, K.
    Yoshinami, T.
    Ohtani, S.
    Kai, Y.
    Takano, T.
    Yanagita, Y.
    Morita, S.
    Toi, M.
    Ohno, S.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S100 - S100
12345